Cogent Biosciences
(NASDAQ) COGT
Cogent Biosciences Financials at a Glance
Market Cap
$5.65B
Revenue (TTM)
$0.00
Net Income (TTM)
-$354.30M
EPS (TTM)
-$2.52
P/E Ratio
-13.11
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$33.16
Volume
16,580
Open
$33.52
Price
$33.16
Volume
16,580
Open
$33.52
Previous Close
$33.07
Daily Range
$32.95 - $33.80
52-Week Range
$6.92 - $43.73
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$33.16
Volume
16,580
Open
$33.52
Previous Close
$33.07
Daily Range
$32.95 - $33.80
52-Week Range
$6.92 - $43.73
Estimated Earnings Date
Aug 4, 2026
COGT News
COGT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cogent Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
258
CEO
Andrew R. Robbins, MBA
Website
www.cogentbio.comHeadquarters
Waltham, MA 02140, US
COGT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-86%
Return on Capital
-43%
Return on Assets
-39%
Earnings Yield
-7.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.65B
Shares Outstanding
170.91M
Volume
16.58K
Avg. Volume
2.14M
Financials (TTM)
Gross Profit
-$4.62M
Operating Income
-$333.36M
EBITDA
-$321.26M
Operating Cash Flow
-$264.44M
Capital Expenditure
-$1.55M
Free Cash Flow
-$266.00M
Cash & ST Invst.
$900.77M
Total Debt
$253.15M
Cogent Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$1.16M
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.65B
N/A
Market Cap/Employee
$27.57M
N/A
Employees
205
N/A
Net Income
-$97.35M
-35.2%
EBITDA
-$94.98M
-34.1%
Quarterly Fundamentals
Total Cash
$866.38M
+252.7%
Total Debt
$238.65M
+1296.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$237.27M
+1432.8%
Short Term Debt
$1.38M
-14.2%
Return on Assets
-39.24%
N/A
Return on Invested Capital
-42.84%
N/A
Free Cash Flow
-$87.33M
-30.2%
Operating Cash Flow
-$86.88M
-30.6%